ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,554.25
      0.20%
      US Tech 100
      18,971.20
      -0.03%
      Dow Jones
      40,659.76
      0.24%
      Brent Oil
      78.75
      -0.11%
      Bitcoin
      58,510.07
      0.09%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Amylyx Pharmaceuticals Inc (AMLX)

      7. Amylyx Pharmaceuticals Inc (AMLX) Financials

      Amylyx Pharmaceuticals Inc

      Amylyx Pharmaceuticals Inc (AMLX)

      NASDAQ
      2.135
      -0.025
      (-1.16%)
      Closed August 19 4:00PM
      Delayed by 15 minutes
      2.14
      0.005
      (0.23%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Amylyx Pharmaceuticals Inc Financial Summary

      The current AMLX market cap is 145.36M. The company's latest EPS is USD 0.7237 and P/E is 2.96.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 71.43M98.22M102.69M108.45M88.64M
      Operating Income -2.05M20.2M18.72M1.93M-11.67M
      Net Income 1.57M22.07M20.89M4.73M-118.79M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 1.43M1.43M285k22.23M380.79M
      Operating Income -13.55M-13.55M-82.69M-201.34M38.8M
      Net Income -13.72M-13.72M-87.93M-198.38M49.27M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 407.96M453.59M466.58M517.45M417.46M
      Total Liabilities 55.31M67.22M48.18M84.02M93.02M
      Total Equity 352.65M386.37M418.4M433.43M324.44M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 3.22M14.1M105.61M391.45M517.45M
      Total Liabilities 20.9M8.77M17.43M50.85M84.02M
      Total Equity -25.36M-66.73M-151.17M340.61M433.43M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -5.07M3.54M-1.63M11.92M-489k
      Investing 55.99M179.22M71.13M92.05M819k
      Financing 1.04M2.42M3.31M3.54M131k
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -10.69M-10.69M-74.8M-179.87M11.92M
      Investing N/A N/A -46.41M-238.99M92.05M
      Financing 668k668k158.51M431.79M3.54M

      Stats and Ratios

      Market Cap 145.36M
      Price to Earnings Ratio 2.96
      Price to Sales Ratio 0.38
      Price to Cash Ratio 0.86
      Price to Book Ratio 0.34
      Dividend Yield -

      Share Statistics

      Shares Outstanding 68.08M
      Average Volume (1 week) 1.29M
      Average Volume (1 Month) 1.07M
      52 Week Change -89.74%
      52 Week High 22.358
      52 Week Low 1.575
      Spread (Intraday) 0.63 (27.63%)

      Company Info

      Company Name Amylyx Pharmaceuticals Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://www.amylyx.com
      Industry pharmaceutical preparations (2834)